...
首页> 外文期刊>Hormones and behavior >Increases in plasma corticosterone and stretched-attend postures in rats naive and previously exposed to the elevated plus-maze are sensitive to the anxiolytic-like effects of midazolam.
【24h】

Increases in plasma corticosterone and stretched-attend postures in rats naive and previously exposed to the elevated plus-maze are sensitive to the anxiolytic-like effects of midazolam.

机译:天真和先前暴露于高迷宫的大鼠血浆皮质类固醇激素的增加和伸展的姿势对咪达唑仑的抗焦虑作用很敏感。

获取原文
获取原文并翻译 | 示例

摘要

A single exposure to the elevated plus-maze test (EPM) reduces or abolishes the anxiolytic efficacy of benzodiazepines on a second trial. This phenomenon known as one-trial tolerance (OTT) is considered to be due to a shift in the emotional state of the animals across the test/retest sessions. Activation of the hypothalamic-pituitary-adrenocortical (HPA) axis has been considered to be an adaptive response to stressful or challenging situations such as height and openness of the EPM. This work looks at the phenomenon of OTT to the benzodiazepine compound midazolam through the conjoint examination of the novel ethological measures of the EPM and adrenocortical response of rats exposed to single and repeated sessions of the EPM. The results obtained confirmed that the approach/avoidance conflict on the first trial of the EPM is very sensitive to the anxiolytic effects of benzodiazepines. Moreover, stressful stimuli present upon initial exposure to the EPM render the standard measures of the EPM resistant to the anxiolytic effects of benzodiazepines on retest. However, the increases in plasma corticosterone and in risk assessment behavior observed in rats submitted to single or repeated sessions in the EPM were reversed by pretreatment with midazolam. The administration of metyrapone, a glucocorticoid synthesis blocker, decreased risk assessment but did not affect locomotion and anxiety-like behaviors. It is suggested that the detection of the dangerous environment through the stretched-attend postures in the second trial leads to the known low level of exploration and the consequent OTT upon retest. Moreover, in view of the similarity between the risk assessment and plasma corticosterone patterns in both naive and experienced rats, this hormone-behavior profile may be crucial for the expression of OTT to benzodiazepines in rodents exposed to the EPM.
机译:在第二项试验中,单次暴露于高迷迷宫试验(EPM)中会降低或消除苯二氮卓类药物的抗焦虑作用。这种现象被称为一审耐受(OTT),被认为是由于动物在整个测试/重测过程中的情绪状态发生了变化。下丘脑-垂体-肾上腺皮质(HPA)轴的激活被认为是对压力或挑战性情况(例如EPM的高度和开放度)的适应性反应。这项工作通过对EPM的新的行为学测量方法和暴露于单次或多次EPM的大鼠的肾上腺皮质反应的联合检查,研究了OTT对苯二氮卓类化合物咪达唑仑的现象。获得的结果证实,EPM首次试验中的方法/避免冲突对苯二氮卓类药物的抗焦虑作用非常敏感。此外,最初暴露于EPM时出现的压力刺激使EPM的标准措施抵抗了苯二氮卓类药物对复试的抗焦虑作用。然而,用咪达唑仑预处理可以逆转在EPM中进行单次或重复训练的大鼠血浆皮质类固醇激素的增加和风险评估行为。甲吡酮(一种糖皮质激素合成阻滞剂)的使用降低了风险评估,但并未影响运动和焦虑样行为。建议在第二次试验中通过张紧的坐姿检测危险环境会导致已知的低探测水平,并因此导致重新测试时的OTT。此外,鉴于在幼稚和有经验的大鼠中风险评估与血浆皮质酮模式之间的相似性,这种激素行为特征对于暴露于EPM的啮齿动物中OTT向苯并二氮杂的表达可能至关重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号